Literature DB >> 27653908

Differences between the behavioral and psychological symptoms of Alzheimer's disease and Parkinson's disease.

Ryo Tokuchi1, Nozomi Hishikawa2, Kota Sato2, Noriko Hatanaka2, Yusuke Fukui2, Mami Takemoto2, Yasuyuki Ohta2, Toru Yamashita2, Koji Abe3.   

Abstract

AIM: We compared the behavioral and psychological symptoms of Alzheimer's disease (AD) and Parkinson's disease (PD) in order to determine the characteristic features of each disorder.
METHODS: For this retrospective cohort study, we compared the behavioral and psychological symptoms of 288AD patients and 189 PD patients (mean age, 74.6±5.9 and 73.0±8.7years respectively). Symptoms were evaluated using the geriatric depression scale (GDS), apathy scale (AS), and Abe's behavioral and psychological symptoms of dementia score (ABS).
RESULTS: AD patients had higher AS and ABS scores than PD patients. A gender-dependent comparison showed that ABS scores were worse in female AD patients than in female PD patients (p=0.001). A subscale analysis of ABS scores revealed that male AD patients were only significantly different from male PD patients in 1 item, whereas female AD patients were significantly different from female PD patients in 4 items. Among patients with mild cognitive decline, no differences in affective scores were observed. Alternatively, among patients with moderate cognitive decline, affective scores on all 3 scales were worse in PD patients than in AD patients.
CONCLUSIONS: The present age- and gender-matched retrospective analysis identified greater behavioral and psychological disease severity in female AD patients relative to female PD patients, and greater affective severity in PD patients versus AD patients with a similar degree of cognitive decline.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Behavioral and psychological symptoms; Parkinson's disease

Mesh:

Year:  2016        PMID: 27653908     DOI: 10.1016/j.jns.2016.08.053

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline.

Authors:  Zhi Zhou; Martijn L T M Müller; Prabesh Kanel; Jason Chua; Vikas Kotagal; Daniel I Kaufer; Roger L Albin; Kirk A Frey; Nicolaas I Bohnen
Journal:  Neurology       Date:  2019-11-15       Impact factor: 9.910

Review 2.  PET/MR Imaging: New Frontier in Alzheimer's Disease and Other Dementias.

Authors:  Xin Y Zhang; Zhen L Yang; Guang M Lu; Gui F Yang; Long J Zhang
Journal:  Front Mol Neurosci       Date:  2017-11-01       Impact factor: 5.639

3.  Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer's disease.

Authors:  Martina Svensson; Emelie Andersson; Oscar Manouchehrian; Yiyi Yang; Tomas Deierborg
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

4.  The effect of electroconvulsive therapy on neuroinflammation, behavior and amyloid plaques in the 5xFAD mouse model of Alzheimer's disease.

Authors:  Martina Svensson; Gustaf Olsson; Yiyi Yang; Sara Bachiller; Maria Ekemohn; Joakim Ekstrand; Tomas Deierborg
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

5.  The congruency of neuropsychological and F18-FDG brain PET/CT diagnostics of Alzheimer's Disease (AD) in routine clinical practice: insights from a mixed neurological patient cohort.

Authors:  Sascha Hansen; Jana Keune; Kim Küfner; Regina Meister; Juliane Habich; Julia Koska; Stefan Förster; Patrick Oschmann; Philipp M Keune
Journal:  BMC Neurol       Date:  2022-03-09       Impact factor: 2.474

6.  T1-weighted MRI-driven Brain Age Estimation in Alzheimer's Disease and Parkinson's Disease.

Authors:  Iman Beheshti; Shiwangi Mishra; Daichi Sone; Pritee Khanna; Hiroshi Matsuda
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

7.  Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model.

Authors:  ChaoYuan Song; MaoYu Li; LinLin Xu; Yang Shen; Hui Yang; Mao Ding; XiangTian Liu; ZhaoHong Xie
Journal:  Neuroreport       Date:  2018-12-12       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.